441 results on '"de Vos F"'
Search Results
2. Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol
3. Prognostic factors among patients with brain metastases from cancer of unknown primary site
4. Blended online learning for oncologists to improve skills in shared decision making about palliative chemotherapy: a pre-posttest evaluation
5. Cortical motor threshold determination in dogs
6. Changes in canine cerebral perfusion after accelerated high frequency repetitive transcranial magnetic stimulation (HF-rTMS): A proof of concept study
7. Interlaboratory variability of Ki67 staining in breast cancer
8. Medulloblastoma in adults:evaluation of the Dutch society for neuro-oncology treatment protocol
9. Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020)
10. Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol
11. Blended online learning for oncologists to improve skills in shared decision making about palliative chemotherapy: a pre-posttest evaluation
12. OS09.7.A Experiences and unmet needs of grade 2-4 glioma patients and (health care) professionals regarding (return to) work: the BrainWork study
13. Centralized proton therapy for medulloblastoma; an evaluation of the care infrastructure
14. A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
15. MO-0061 Centralized proton therapy for medulloblastoma; an evaluation of the care infrastructure.
16. MO-0724 Impact of irradiation of the neurogenic niches on survival in patients with brain metastases
17. Prognostic factors among patients with brain metastases from cancer of unknown primary site
18. Synthesis and Evaluation of [123I]Iodoaminoglutethimide, a Ligand for Visualization of the Aromatase Enzyme by Spect
19. Use of Neuroimaging Techniques in Glioma Patients – Results of an International Survey on behalf of the EORTC Brain Tumor Group
20. Membrane technologies for water treatment and reuse in the power industries
21. List of contributors
22. P14.17 Conventional MRI criteria differentiate true tumour progression from treatment-induced effects in irradiated WHO grade 3 and 4 gliomas
23. P14.13 Severe hematological toxicity during chemoradiation for glioblastoma: Identification of clinical and pharmacological risk factors and consequences for the individual patient
24. [Ceylon Notes and Queries Part I, October, 1913]
25. CONVENTIONAL MRI CRITERIA DIFFERENTIATE TRUE TUMOUR PROGRESSION FROM TREATMENT-INDUCED EFFECTS IN IRRADIATED WHO GRADE 3 AND 4 GLIOMAS
26. In vivo Toxicity and Bioavailability of Taxol® and a Paclitaxel/β-Cyclodextrin Formulation in a Rat Model During HIPEC
27. Effect of cyclosporin A administration on the biodistribution and multipinhole μSPECT imaging of [123I]R91150 in rodent brain
28. INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma
29. Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool
30. Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool
31. Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide
32. Biodistribution and dosimetry of (iodine-123)-iodomethyl-N,N-diethyltamoxifen, an (anti)oestrogen receptor radioligand
33. Protein encapsulation in polyelectrolyte microcapsules for antigen delivery
34. Bevacizumab bij symptomatische cerebrale radiatienecrose
35. A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors
36. EDITORIAL
37. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195
38. Biodistribution and displacement studies of the selective 5-HT2Areceptor antagonist 123I-5-I-R91150 in the normal dog
39. An open label prospective study of imaging with a 131-I labelled super high affinity chimaeric monoclonal antibody targeted against CEA in patients with metastatic colorectal carcinoma
40. P14.124 EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with standard temozolomide-based radiochemotherapy versus standard temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma
41. OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study
42. SP-0110 Magnetic resonance based small animal radiotherapy in neuro-oncology
43. A randomized controlled trial of a skills training for oncologists and a communication aid for patients to stimulate shared decision making about palliative systemic treatment (CHOICE) : study protocol
44. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI
45. A randomized controlled trial of a skills training for oncologists and a communication aid for patients to stimulate shared decision making about palliative systemic treatment (CHOICE): study protocol
46. In vivo evaluation of 4-[ 123I]iodo-N-{2-[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl}benzamide, a potential SPECT radioligand for the 5-HT 1A receptor
47. Interlaboratory variability of Ki67 staining in breast cancer
48. Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma
49. Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma : Response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): Study protocol of a phase II, open-label, multicenter study
50. Het portfolio zal de kwaliteit van de specialistenopleiding vergroten
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.